Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,800
Closed -$398K 170
2023
Q4
$398K Buy
+3,800
New +$351K 0.01% 137
2021
Q2
Sell
-367,600
Closed -$39.6M 218
2021
Q1
$39.6M Buy
367,600
+14,400
+4% +$1.6M 0.42% 80
2020
Q4
$41.5M Buy
353,200
+26,800
+8% +$2.73M 0.47% 61
2020
Q3
$28M Buy
326,400
+26,200
+9% +$2.24M 0.39% 72
2020
Q2
$23.8M Buy
+300,200
New +$23.4M 0.34% 71
2017
Q3
Sell
-10,000
Closed -$648K 133
2017
Q2
$648K Hold
10,000
0.08% 121
2017
Q1
$680K Hold
10,000
0.09% 114
2016
Q4
$642K Hold
10,000
0.13% 102
2016
Q3
$661K Sell
10,000
-3,000
-23% -$211K 0.12% 111
2016
Q2
$1M Sell
13,000
-7,000
-35% -$529K 0.19% 97
2016
Q1
$1.47M Buy
+20,000
New +$1.35M 0.27% 87

Other funds holding DVA

Bellevue Group's DVA Position: Q1 2024 in Review

Bellevue Group sold out of DaVita (DVA) in Q1 2024, closing a stake of 3,800 shares — an estimated $398K sold.

Bellevue Group first reported a position in DVA in Q1 2016 and held it in 11 quarters. The position peaked at $41.5M in Q4 2020. 544 funds tracked by Wall St. Rank hold DVA as of Q1 2024.

  • Bellevue Group reported no remaining DaVita position as of Q1 2024 after selling out during the quarter.
  • Bellevue Group sold 3,800 DaVita shares in Q1 2024, an estimated $398K.
  • Bellevue Group first reported a position in DaVita in Q1 2016 and held it in 11 quarters.
  • Bellevue Group's DaVita position peaked at $41.5M in Q4 2020.
  • 544 funds tracked by Wall St. Rank held DaVita as of Q1 2024.

Based on Bellevue Group's 13F filing for Q1 2024, filed 15 May 2024.